Transient limb ischemia alters serum protein expression in healthy volunteers: Complement C3 and vitronectin may be involved in organ protection induced by remote ischemic preconditioning

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Pang, Ting ^a   Zhao, Yang ^a   Zhang, Nan Rong ^a   Jin, San Qing ^a   Pan, San Qiang ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENT COMPONENT C3; VITRONECTIN;

ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIMB; MALE; MASS SPECTROMETRY; METABOLISM; NORMAL HUMAN; PATHOLOGY; PEPTIDE MAPPING; PROTEOMICS; REPRODUCIBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASCULARIZATION; WESTERN BLOTTING; YOUNG ADULT;

APOLIPOPROTEIN A-I; BLOTTING, WESTERN; COMPLEMENT C3; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTREMITIES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; ISCHEMIA; ISCHEMIC PRECONDITIONING; MALE; MASS SPECTROMETRY; PEPTIDE MAPPING; PROTEOMICS; REPRODUCIBILITY OF RESULTS; VITRONECTIN; YOUNG ADULT;

MLCS; MLOWN;

EID: 84893820713     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/859056     Document Type: Article

References (37)

1. Murry C. E., Jennings R. B., Reimer K. A., Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986 74 5 1124 1136 2-s2.0-0022970945 (Pubitemid 17174962)
2. Przyklenk K., Bauer B., Ovize M., Kloner R. A., Whittaker P., Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993 87 3 893 899 2-s2.0-0027401466 (Pubitemid 23070821)
3. Kharbanda R. K., Mortensen U. M., White P. A., Kristiansen S. B., Schmidt M. R., Hoschtitzky J. A., Vogel M., Sorensen K., Redington A. N., MacAllister R., Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002 106 23 2881 2883 2-s2.0-0037016064 10.1161/01.CIR.0000043806. 51912.9B (Pubitemid 35424735)
4. Hausenloy D. J., Mwamure P. K., Venugopal V., Harris J., Barnard M., Grundy E., Ashley E., Vichare S., Di Salvo C., Kolvekar S., Hayward M., Keogh B., MacAllister R. J., Yellon D. M., Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. The Lancet 2007 370 9587 575 579 2-s2.0-34547837402 10.1016/S0140-6736(07)61296-3 (Pubitemid 47247853)
5. Hoole S. P., Heck P. M., Sharples L., Khan S. N., Duehmke R., Densem C. G., Clarke S. C., Shapiro L. M., Schofield P. M., O'Sullivan M., Dutka D. P., Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study. A prospective, randomized control trial. Circulation 2009 119 6 820 827 2-s2.0-61949111375 10.1161/CIRCULATIONAHA.108.809723
6. Rentoukas I., Giannopoulos G., Kaoukis A., Kossyvakis C., Raisakis K., Driva M., Panagopoulou V., Tsarouchas K., Vavetsi S., Pyrgakis V., Deftereos S., Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention. enhancement by opioid action. JACC: Cardiovascular Interventions 2010 3 1 49 55 2-s2.0-74049108136 10.1016/j.jcin.2009.10.015
7. Bøtker H. E., Kharbanda R., Schmidt M. R., Bøttcher M., Kaltoft A. K., Terkelsen C. J., Munk K., Andersen N. H., Hansen T. M., Trautner S., Lassen J. F., Christiansen E. H., Krusell L. R., Kristensen S. D., Thuesen L., Nielsen S. S., Rehling M., Sørensen H. T., Redington A. N., Nielsen T. T., Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. The Lancet 2010 375 9716 727 734 2-s2.0-77249107745 10.1016/S0140-6736(09)62001-8
8. Loukogeorgakis S. P., Panagiotidou A. T., Broadhead M. W., Donald A., Deanfield J. E., MacAllister R. J., Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. Journal of the American College of Cardiology 2005 46 3 450 456 2-s2.0-22844432697 10.1016/j.jacc.2005.04.044 (Pubitemid 41040285)
9. Dickson E. W., Reinhardt C. P., Renzi F. P., Becker R. C., Porcaro W. A., Heard S. O., Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidence. Journal of Thrombosis and Thrombolysis 1999 8 2 123 129 2-s2.0-0032873451 10.1023/A:1008911101951 (Pubitemid 29410837)
10. Dickson E. W., Lorbar M., Porcaro W. A., Fenton R. A., Reinhardt C. P., Gysembergh A., Przyklenk K., Rabbit heart can be "preconditioned" via transfer of coronary effluent. The American Journal of Physiology-Heart and Circulatory Physiology 1999 277 6 H2451 H2457 2-s2.0-0033401247 (Pubitemid 30048169)
11. Shimizu M., Tropak M., Diaz R. J., Suto F., Surendra H., Kuzmin E., Li J., Gross G., Wilson G. J., Callahan J., Redington A. N., Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clinical Science 2009 117 5 191 200 2-s2.0-67649612042 10.1042/CS20080523
12. Zhao Y., Zheng Z. N., Jin S. Q., Liang H. M., Effects of plasma collected 48 hours after transient limb ischemia on blood pressure recovery in homogenic rats after myocardial ischemia reperfusion in vivo. Chinese Medical Journal 2013 126 15 2894 2899
13. Lang S. C., Elsässer A., Scheler C., Vetter S., Tiefenbacher C. P., Kübler W., Katus H. A., Vogt A. M., Myocardial preconditioning and remote renal preconditioning-identifying a protective factor using proteomic methods? Basic Research in Cardiology 2006 101 2 149 158 (Pubitemid 43250807)
14. Serejo F. C., Rodrigues L. F. Jr., da Silva Tavares K. C., de Carvalho A. C. C., Nascimento J. H. M., Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. Journal of Cardiovascular Pharmacology 2007 49 4 214 220 2-s2.0-34247235198 10.1097/FJC.0b013e3180325ad9 (Pubitemid 46626013)
15. Hepponstall M., Ignjatovic V., Binos S., Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans. PLoS ONE 2012 7 11 e48284
16. Hausenloy D. J., Yellon D. M., Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovascular Research 2008 79 3 377 386 2-s2.0-48749128031 10.1093/cvr/cvn114
17. Pell T. J., Baxter G. F., Yellon D. M., Drew G. M., Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. The American Journal of Physiology-Heart and Circulatory Physiology 1998 275 5 H1542 H1547 2-s2.0-0031756415
18. Schoemaker R. G., van Heijningen C. L., Bradykinin mediates cardiac preconditioning at a distance. The American Journal of Physiology-Heart and Circulatory Physiology 2000 278 5 H1571 H1576 2-s2.0-0034130266 (Pubitemid 30395568)
19. Tang Z. L., Dai W., Li Y. J., Deng H. W., Involvement of capsaicin-sensitive sensory nerves in early and delayed cardioprotection induced by a brief ischaemia of the small intestine. Naunyn-Schmiedeberg's Archives of Pharmacology 1999 359 243 247 (Pubitemid 29142876)
20. Konstantinov I. E., Arab S., Kharbanda R. K., Li J., Cheung M. M. H., Cherepanov V., Downey G. P., Liu P. P., Cukerman E., Coles J. G., Redington A. N., The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiological Genomics 2005 19 143 150 2-s2.0-19944391882 10.1152/physiolgenomics.00046.2004 (Pubitemid 40039920)
21. Ikai M., Itoh M., Joh T., Yokoyama Y., Okada N., Okada H., Complement plays an essential role in shock following intestinal ischaemia in rats. Clinical and Experimental Immunology 1996 106 1 156 159 2-s2.0-0029738623 (Pubitemid 26329395)
22. Pemberton M., Anderson G. L., Vetvicka V., Justus D. E., Ross G. D., Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. The Journal of Immunology 1993 150 11 5104 5113 2-s2.0-0027299177 (Pubitemid 23150378)
23. Toomayan G. A., Chen L. E., Jiang H. X., Qi W. N., Seaber A. V., Frank M. M., Urbaniak J. R., C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle. Microsurgery 2003 23 6 561 567 2-s2.0-0346368162 10.1002/micr.10210 (Pubitemid 38049965)
24. de Vries B., Matthijsen R. A., Wolfs T. G. A. M., van Bijnen A. A. J. H. M., Heeringa P., Buurman W. A., Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003 75 3 375 382 2-s2.0-0037442163 10.1097/01.TP.0000044455.05584.2A (Pubitemid 36222966)
25. Tanhehco E. J., Yasojima K., McGeer P. L., Washington R. A., Kilgore K. S., Homeister J. W., Lucchesi B. R., Preconditioning reduces tissue complement gene expression in the rabbit isolated heart. The American Journal of Physiology-Heart and Circulatory Physiology 1999 277 6 H2373 H2380 2-s2.0-0033379024 (Pubitemid 30048159)
26. Tanhehco E. J., Yasojima K., McGeer P. L., McGeer E. G., Lucchesi B. R., Preconditioning reduces myocardial complement gene expression in vivo. The American Journal of Physiology-Heart and Circulatory Physiology 2000 279 3 H1157 H1165 2-s2.0-0033834774
27. Muscari A., Massarelli G., Bastagli L., Poggiopollini G., Tomassetti V., Drago G., Martignani C., Pacilli P., Boni P., Puddu P., Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. European Heart Journal 2000 21 13 1081 1090 2-s2.0-0034094983 10.1053/euhj.1999.2013 (Pubitemid 30352992)
28. Zheng X., Lian D., Wong A., Bygrave M., Ichim T. E., Khoshniat M., Zhang X., Sun H., de Zordo T., Lacefield J. C., Garcia B., Jevnikar A. M., Min W.-P., Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation 2009 120 12 1099 1107 2-s2.0-70349664187 10.1161/CIRCULATIONAHA.108.787390
29. Mocco J., Mack W. J., Ducruet A. F., Sosunov S. A., Sughrue M. E., Hassid B. G., Nair M. N., Laufer I., Komotar R. J., Holland M. C. H., Pinsky D. J., Connolly E. S. Jr., Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circulation Research 2006 99 2 209 217 2-s2.0-33747598070 10.1161/01.RES.0000232544.90675.42 (Pubitemid 44297045)
30. Seiffert D., Schleef R. R., Two functionally distinct pools of vitronectin (Vn) in the blood circulation: Identification of a heparin-binding competent population of Vn within platelet α -granules. Blood 1996 88 2 552 560 2-s2.0-0029953975 (Pubitemid 26240387)
31. Zhuang P., Blackburn M. N., Peterson C. B., Characterization of the denaturation and renaturation of human plasma vitronectin I. Biophysical characterization of protein unfolding and multimerization. Journal of Biological Chemistry 1996 271 24 14323 14332 2-s2.0-0029999152
32. Ekmekci H., Sonmez H., Ekmekci O. B., Ozturk Z., Domanic N., Kokoglu E., Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. Journal of Thrombosis and Thrombolysis 2002 14 3 221 225 2-s2.0-0041412714 10.1023/A:1025000810466 (Pubitemid 37069305)
33. Yamani M. H., Tuzcu E. M., Starling R. C., Ratliff N. B., Yu Y., Vince D. G., Powell K., Cook D., McCarthy P., Young J. B., Myocardial ischemic injury after heart transplantation is associated with upregulation of vitronectin receptor (α (v) β 3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy. Circulation 2002 105 16 1955 1961 2-s2.0-0037161364 10.1161/01.CIR.0000014971. 09169.BC (Pubitemid 34437624)
34. Derer W., Barnathan E. S., Safak E., Agarwal P., Heidecke H., Mockel M., Gross M., Oezcelik C., Dietz R., Dechend R., Vitronectin concentrations predict risk in patients undergoing coronary stenting. Circulation: Cardiovascular Interventions 2009 2 1 14 19 2-s2.0-77953673288 10.1161/CIRCINTERVENTIONS.108. 795799
35. Barter P. J., Nicholls S., Rye K. A., Anantharamaiah G. M., Navab M., Fogelman A. M., Antiinflammatory properties of HDL. Circulation Research 2004 95 8 764 772 2-s2.0-6344253356 10.1161/01.RES.0000146094.59640.13 (Pubitemid 39390578)
36. Mineo C., Deguchi H., Griffin J. H., Shaul P. W., Endothelial and antithrombotic actions of HDL. Circulation Research 2006 98 11 1352 1364 2-s2.0-33745369351 10.1161/01.RES.0000225982.01988.93 (Pubitemid 43948059)
37. Shi N., Wu M. P., Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats. Journal of Biomedical Science 2008 15 5 577 583 2-s2.0-51349103417 10.1007/s11373-008-9258-7